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Abstract: Background: Multiple sclerosis (MS) is associated with lower quality of life, reduced social
participation, and decreased self-efficacy. The COVID-19 pandemic has had documented effects
on the health and wellbeing of people with and without MS. Previous research has demonstrated
the positive impact pets can have for people living with long-term conditions. Objectives: To
explore the rates of pet ownership and pet attachment in people living with MS and pet ownership
associations with quality of life, satisfaction with social roles, and self-efficacy scores; and to explore
the effects of the COVID-19 outbreak on people’s perceived relationships with their pets. Materials
and Methods: A postal questionnaire was distributed to members of a local MS Register and a control
group of people without MS. The questionnaire assessed quality of life, satisfaction with social roles,
self-efficacy, the perceived roles of pets, and pet-related concerns experienced during the COVID-19
pandemic. Results: No apparent difference in attachment to pets was found between the patient
and control groups. Pet ownership and level of attachment were not associated with differences
in quality of life or self-efficacy scores in people living with MS. Using multiple regression analysis,
pet ownership was associated with a decrease in satisfaction with participation in social roles, but
with the estimated effect being small compared to having a diagnosis of MS or being unemployed.
Most participants reported that pets had positive roles during the pandemic, and the most reported
pet-related concern was access to veterinary treatment. Conclusion: Pet owners both with and
without MS reported subjective benefits to their wellbeing from pet ownership during COVID-19,
although analysis suggested that pet ownership was associated with a reduction in satisfaction with
social roles. The study had several limitations and suggestions are made for future work.
Keywords: multiple sclerosis; pet ownership; COVID-19; quality of life
1. Introduction
Multiple sclerosis (MS) is a demyelinating disease that affects the central nervous
system. It can cause a wide range of signs and symptoms, with motor, cognitive, and
emotional effects among others. Fatigue, depression, impaired bladder and bowel control,
muscle weakness and stiffness, cognitive impairment, and pain are common [1–4] and it
is perhaps unsurprising that people with MS (PwMS) have reduced quality of life [5,6],
mood [7], and social participation [8] compared to people without MS.
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There is some evidence that pet ownership can benefit health and wellbeing across
a variety of conditions [9,10], increasing life satisfaction, engendering a sense of responsi-
bility and routine, and providing unconditional love, companionship, social interaction,
and physical contact [11–13]. Individuals with chronic physical and/or mental health
conditions often report that their pets improve their quality of life and help with symptom
management [14,15].
Self-efficacy is the belief in one’s ability to succeed in specific situations or accomplish
tasks [16]. It has been identified as a key factor in people being able to live successfully with
the multiple challenges of chronic illnesses [17]. In MS, enhancing self-efficacy has been
shown to improve health-related quality of life and reduce anxiety and depression [18,19].
Previous work in health and in chronic illness supports the notion that pet ownership
improves self-efficacy [13,20].
Social roles are a way of defining how individuals behave and function in different
groups, at work, at home, and at leisure. People participate in society at many different
levels, as workers, family members, colleagues, friends, etc. People living with chronic
illness often experience physical, psychological, and social barriers to full participation
in society and societal roles [21], and may find it harder to relate to individuals, groups,
and the overall community. Satisfaction with social roles has been shown to be reduced
in PwMS [22]. We hypothesized that, particularly in individuals who may be more socially
isolated, the companionship and “job of work” associated with caring for a pet may
generate more satisfaction with social roles. In some chronic conditions, satisfaction with
social roles is thought to mediate the relationships between symptoms or functioning and
emotional outcomes [23].
Pet attachment can provide a form of social support and has been identified as be-
ing important in some people living with chronic illness [11], lessening the impact of
social isolation [24].
The potential psychosocial benefits of pet ownership have not yet been explored in MS.
The COVID-19 pandemic has led to major changes in social interaction and concerns
about risks of infection, particularly in those with underlying health conditions. Through-
out the pandemic, higher than normal levels of both depression and anxiety have been
recorded in the UK population [25]. PwMS have experienced a greater burden of de-
pressive symptoms, worse sleep quality, and perceived increases in levels of fatigue than
the general population [26–28], potentially exacerbating existing problems and further
increasing inequalities in the health status between PwMS and those without MS.
Recent research suggests that pet ownership may have helped many people to cope
during the COVID-19 pandemic. An online survey of pet owners reported that over 80%
of respondents felt that their pets helped them to cope emotionally with COVID-19, and
over 90% of participants said that they could not imagine being without their pet at this
time [29]. Despite this, over 50% of people surveyed experienced pet-related worries,
including accessibility to and affordability of veterinary care [29,30]. Animal ownership
was associated with smaller decreases in mental health and smaller increases in loneliness
during the pandemic [29].
1.1. Objectives
1. To explore the rates of pet ownership and associations with quality of life, satisfaction
with social roles, and self-efficacy scores in PwMS.
2. To compare the levels of attachment to pets in PwMS and people without MS.
3. To compare the levels of satisfaction with social roles in pet-owning and non-pet-
owning PwMS and people without MS.
4. To explore the effects of the COVID-19 outbreak on people’s perceived relationships
with their pets (how the participants thought their pets helped them emotionally and
physically and whether they had any concerns about being a pet owner during the
COVID-19 pandemic).
Int. J. Environ. Res. Public Health 2021, 18, 12683 3 of 17
1.2. Hypotheses:
1. Pet ownership is associated with higher rates of quality of life, self-efficacy, and
satisfaction with social roles in PwMS.
2. Pet attachment may be higher in PwMS than in controls.
3. Satisfaction with social roles may be higher in pet-owning than non-pet-owning
PwMS and controls.
4. Objective 4 is exploratory; no specific hypothesis generated.
2. Materials and Methods
The study received ethical approval from Social Care Research Ethics Committee
(IRAS ID 261959) and the sponsor was the University of Nottingham (ref 19070).
2.1. Study Design
This was a cross-sectional questionnaire study involving PwMS as cases and con-
trols (people without a diagnosis of MS). Cases and controls were subsequently further
subdivided by pet ownership status, into pet owners and non-pet owners.
2.2. Population
PwMS/Cases/Patients: Patients with a confirmed diagnosis of MS were recruited from
the MS Register maintained at Nottingham University Hospitals NHS Trust. A question-
naire pack (containing invitation letter, information letter, questionnaire, and stamped
addressed envelope as well as 2 “control packs” containing the same material) was posted
to 800 individuals on this register. Patients receiving the questionnaire were asked if they
would be willing to pass on one or two questionnaires to “controls” (defined as friends or
non-blood relatives of the person with MS).
Inclusion criteria:
• Aged 18 years or over.
• Diagnosis of MS AND on the Nottingham MS Register.
Exclusion criteria:
• Inability or unwillingness to complete the questionnaire.
Controls: Recruited patients were given the option of recruiting one or two friends or
non-blood relatives without MS to whom they could pass on one of the “control packs”.
Inclusion criteria:
• Aged 18 years or over.
• Friend or non-blood relative of person with MS diagnosis.
• Not diagnosed with MS.
Exclusion criteria:
• Inability or unwillingness to complete questionnaire.
2.3. Questionnaire
The questionnaire comprised multiple-choice and short-answer questions including
some validated questionnaires.
2.4. Demographic Data
Demographic data collected included current age, gender, employment status, and MS
subtype (primary progressive (PP)MS/progressive relapsing (PR)MS/relapsing remitting
(RR)MS/secondary progressive (SP)MS/Other/Not sure).
Data were not collected about co-morbidities.
2.5. Pet Ownership
Participants were asked to answer ‘yes’ or ‘no’ in response to the question, ‘do you
own any pets?’. If participants answered ‘yes’, they were asked to record the species and
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number of pets owned. Pet owners and non-pet owners were invited to complete all
parts of the questionnaire apart from those questions relating specifically to relationships
with pets (e.g., the Lexington attachment to pets scale; perceived roles of pets during
the pandemic).
There was no restriction by type or number of pets.
Attachment to pets: Attachment to pets was assessed using the validated Lexington
attachment to pets scale (LAPS), a 23-item questionnaire scored using a Likert scale with
excellent psychometric properties [31]. Negative statements were scored in reverse and
individual question scores were added to generate a total score. Higher scores indicate
greater attachment.
Satisfaction with (participation in) social roles (SPSR): This was measured using
the Patient-Reported Outcomes Measurement Information System (PROMIS) 8-item short
form with a 5-point Likert scale, with the raw score being converted into a standardized “T”
score, with higher scores indicating greater satisfaction with social roles. This is suitable
for use in a postal questionnaire, being reliable, quick, and easy to complete [32,33].
Quality of life (QoL): QoL was assessed using the Leeds Multiple Sclerosis Quality
of Life scale (LMS-QoL), an eight-item measure of QoL designed specifically for use
by PwMS [34]. The instrument is brief, easy to complete, and provides a valid measure
of wellbeing-associated QoL in PwMS [34–36]. Higher scores indicate a lower quality of life.
Self-efficacy: This was assessed using the 12-item Unidimensional Self-Efficacy scale
for Multiple Sclerosis (USE-MS) [37]. It is both a reliable and valid means of assessing
self-efficacy in PwMS [37]. Higher scores indicate increased self-efficacy.
Perceived roles of pets during the pandemic: Participants were asked to indicate
their level of agreement with a series of five statements regarding the roles of their pets dur-
ing the pandemic using a Likert scale with the following answer options: ‘strongly agree’,
‘somewhat agree’, ‘disagree’, ‘strongly disagree’. The statements included concerned the
effects of pets on family (having positive effects or causing problems), physical activity
(“keeping fit and active”), social interaction (“my animal is the reason I keep in touch with
some people and social media groups”), and emotional coping (“my animal helps me cope
emotionally with the COVID-19 situation”) during the pandemic. Participants were also
asked to answer ‘yes’, ‘no’, or ‘prefer not to say’ to indicate if they had considered giving
up their pet due to COVID-19.
Potential pet-related causes of concern were also listed (e.g., financial difficulties/buying
pet food/access to veterinary treatment), and participants were asked to indicate whether
any were applicable. Space was given for participants to list any concerns that were not
included in the list.
The questions listed regarding the COVID-19 pandemic were all used in previous
research conducted during the pandemic [29].
Although all measures were included in the questionnaires sent to participants
in the patient group, control questionnaires did not include LMS-QoL or USE-MS questions
as these elements are designed to be MS specific.
Therefore, the following sections were asked and completed by the following groups
(Table 1):
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Age, gender, employment status X X X X
MS subtype X X
Pet ownership (yes/no) X X X X
Details of current pets (type and
number) X X
Attachment to pets (LAPS) X X
Satisfaction with social roles (SPSR) X X X X
Quality of life (QoL/LMS-QoL) X X
Self-efficacy (USE-MS) X X
Pets during COVID-19 X X
No incentives were provided for questionnaire completion. Pre-paid, stamped, and
addressed envelopes were provided for return of questionnaires.
2.6. Data Processing
Pre-existing guidelines and discussions with the questionnaire developers guided
approaches to missing data. The minimum number of questions required to be answered
for each questionnaire were as follows:
21 (out of 23) for LAPS.
4 (out of 8) for SPSR.
5 (out of 8) for LMS-QoL.
6 (out of 12) for USE-MS.
Imputation from existing answers was used for missing data if the minimum number
of questions had been answered but some were unanswered. Forms with less than the
minimum required number of questions completed were excluded.
Questionnaires that were assessed to have been completed erroneously were excluded
(e.g., patients completing control questionnaires; the same control completing duplicate
questionnaires). Assessment was based on handwriting and answers.
2.7. Statistical Analysis
Descriptive statistics were used for the majority of analysis.
Multiple linear regression was used to explore the contribution of the independent
variables of MS status (where applicable), pet ownership, employment status, and living
status, to dependent outcome variables SPSR, QoL, and self-efficacy. The number of pets
and cat/dog ownership was also considered, as was an interaction term between pet
ownership and MS status for SPSR. Each model was controlled for age and sex.
3. Results
Of 800 questionnaires posted, 374 questionnaires were returned (198 PwMS and
176 control), representing a 25% response rate calculated for PwMS responses only, as
the return of control questionnaires was reliant on the distribution by the patient group.
A total of 9 patient questionnaires were excluded based on participants not having received
a diagnosis of MS, leaving 189 for further analysis. Overall, 13 control questionnaires were
excluded due to duplicate completion, leaving 163 for analysis.
3.1. Demographics
Age was similar between PwMS and controls, but a higher proportion of women
responded in the PwMS compared to the control group.
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The most common MS subtype was RRMS.
Employment status differed between the two groups, with higher numbers of med-
ically retired individuals in the MS group and higher rates of employment in the con-
trol group.
The effects of the pandemic, in terms of time spent at home or out of the home, also
differed between the groups, with the MS group having higher numbers of people isolating
at home, and the control group being more likely to carry on as normal.
For full details, please see Table 2.
Table 2. Characteristics of participants. OR: odds ratio. CI: confidence interval (95%).
PwMS (n = 189) Control Group (n = 163) Comparison
Age (mean, standard deviation), years 54, 12 53, 16 Difference in means with 95%CI −1 (−4 to +2)













Not answered 5 (3)
Employment status N (%)
Retired 41 (22) 48 (29)
OR and 95% CI:
0.66 (0.40–1.08)
Medically retired 42 (22) 5 (3) 9.03 (3.5–21.5)
Full time out of the house 37 (20) 57 (35) 0.45 (0.28–0.73)
Full time working from home 11 (6) 11 (7) 0.85 (0.34–1.93)
Part time out of the house 25 (13) 26 (16) 0.80 (0.44–1.48)
Part time working from home 17 (9) 5 (3) 3.1 (1.15–7.86)
Unemployed 14 (7) 7 (4) 1.78 (0.70–4.61)
Other 1 (1) 4 (2) 0.21 (0.02–1.30)
Not answered 1 (1) 0 (0)
Pet owner N (%)
Yes 110 (58) 105 (64) OR 0.77; 95% CI 0.49–1.12
No 79 (42) 58 (36)
Effects of pandemic N (%)
Carried on as normal 29 (15) 62 (38)
OR and 95% CI:
0.30 (0.18–0.49)
Socially distanced but left house regularly 82 (43) 77 (47) 0.86 (0.56–1.30)
Isolated at home for less than 7 days 8 (4) 4 (2) 1.76 (0.53–5.32)
Isolated at home for 8–14 days 5 (3) 4 (2) 1.08 (0.32–3.57)
Isolated at home for more than 14 days 62 (32) 16 (10) 4.49 (2.50–8.10)
Not answered 3 (2) 0 (0)
3.2. Pet Ownership
Over half of the participants in both the MS and control groups reported owning a pet
(PwMS: n = 110, 58%, control: n = 105, 64%). Two members of the MS group reported
spending long periods of time with pets despite not having their own. These people
completed the pet-related questions of the questionnaire, but for the purposes of the study,
both were recorded as non-pet owners and their answers to any pet-related questions were
not included in any data analysis.
Dogs were the most common animal type to be owned in either group (owned by
66% of PwMS and 68% of controls), followed by cats (44% and 48%, respectively). “Other”
pets were owned by 10% of PwMS and 19% of controls, and included rabbits, guinea pigs,
geckos, horses, birds, and fish.
Further characteristics are presented in Table 3.
Int. J. Environ. Res. Public Health 2021, 18, 12683 7 of 17
Table 3. Characteristics of pet owners and non-pet owners in the patient and control groups.
PwMS–Pet
Owners (n = 110)
PwMS–Non-Pet





Owners (n = 105)
Control
Group–Non-Pet
Owners (n = 58)
Comparison
(Control Group)






















OR 0.69; 95% CI
0.36–1.33
MS subtype N (%)
PPMS 5 (5) 10 (13)
OR with 95% CI
0.34 (0.12–0.96)
n/a n/a n/a
PRMS 4 (4) 1 (1) 3.02 (0.48–37.38)
RRMS 64 (58) 45 (57) 1.17 (0.61–2.03)
SPMS 26 (24) 18 (23) 1.08 (0.56–2.22)
Unsure 7 (6) 4 (5) 1.31 (0.40–4.11
Comparing pet owners and non-pet owners showed that in both the MS and the
control group, pet owners tended to be younger than non-pet owners. No differences were
seen in MS subtypes between pet owners and non-pet owners.
3.2.1. Pet Ownership and Multiple Sclerosis–Associations with Quality of Life, Satisfaction
with Social Roles, and Self-Efficacy
Objective 1. To Explore the Rates of Pet Ownership in People Currently Living with
MS and Associations with Quality of Life, Satisfaction with Social Roles and Self-Efficacy
Scores in PwMS.
Hypothesis 1. Pet Ownership Is Associated with Higher Rates of Quality of Life, Self-Efficacy,
and Satisfaction with Social Roles in PwMS.
No significant differences were seen in LMS-QOL, SPSR, and USE-MS scores between
pet owners and non-pet owners living with MS (see Figure 1).
Figure 1. Comparisons of PwMS with and without pets; data displayed as mean +/− 95% confidence intervals. (A) Com-
pares Leeds MS-QOL scores between pet owners (n = 109; mean 11.38; 95% CI 10.5–12.25) and non-pet owners (n = 78; mean
11.05; 95% CI 9.99–12.11). (B) Compares PROMIS short-form 8a scores (assessing satisfaction with social roles) between
pet owners (n = 106; mean = 45.72; 95% CI 43.62–47.81) and non-pet owners (n = 78; mean = 46.58; 95% CI 44.12–49.04).
(C) Compares USE-MS scores between pet owners (n = 109; mean = 18.35; 95% CI 17.00–19.69) and non-pet owners (n = 79;
mean = 18.15; 95% CI 16.71–19.59).
Using the linear regression models, employment was estimated to impact both QoL
(employment reduced the mean QoL score by 2.9 points (standard error 0.79)) and USE-
MS (employment increased the mean USE-MS score by 5.7 points (standard error 1.1)).
Estimates for other factors, as described in the methods section, were much smaller.
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3.2.2. Pet Attachment
Objective 2. To Compare the Levels of Attachment to Pets in PwMS and Controls
(People without MS).
Hypothesis 2. Pet Attachment May Be Higher in PwMS Than in Controls.
Multiple linear regression was used to determine the effect of having a diagnosis of MS
on LAPS score, adjusting for relevant covariates. There was no apparent change in LAPS
score seen with having a diagnosis of MS (1.19 (95% CI [−2.48, 4.87]), age (−0.07 per year,
95% CI −0.22, 0.08), or number of pets (−0.02 per pet; 95% CI −0.59, 0.18). Dog ownership
was associated with an estimated 8.78 increase (95% CI [3.36, 14.19]) in LAPS and the male
gender was associated with an estimated 5.94 decrease (95% CI [−9.89, −2.00]).
3.2.3. Satisfaction with Social Roles in Pet-Owning and Non-Pet-Owning PwMS and
Controls
Objective 3. To Compare Levels of Satisfaction with Social Roles in Pet-Owning and
Non-Pet-Owning PwMS and People without MS.
Hypothesis 3. Satisfaction with Social Roles May Be Higher in Pet-Owning Than Non-Pet-
Owning PwMS and Controls.
Overall, rates of satisfaction with social roles (SPSR) were lower in PwMS than in con-
trols (mean (standard deviation) 46.08 (10.87) in PwMS and 56.44 (9.20) in controls; differ-
ence between means and 95% CI 10.36 (8.22–12.51)).
There was no apparent difference in SPSR between pet-owning and non-pet-owning
PwMS and pet-owning and non-pet-owning controls (see Figure 2).
Figure 2. Comparison of satisfaction with social roles between pet owners and non pet owners with
and without MS.
Using the linear model, the biggest estimated effects on the SPSR score were for:
MS status, which reduced the mean SPSR score by 10 points (standard error (SE) = 1.6);
employment status, which increased the mean score by 10.6 points (SE = 1.2); and being
a pet owner, which reduced the mean score by 3 points (SE = 1.5). Estimates for other
factors were much smaller (Table 4).
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Attachment to pets (LAPS score)
mean and 95% CI 49.0 (46.5–51.6) n/a 46.3 (43.4–49.1) n/a
Satisfaction with social roles
(SPSR) T score mean and 95% CI 45.7 (43.6–47.8) 46.6 (44.1–49.0) 55.8 (53.9–57.8) 57.5 (55.5–59.6)
Quality of life LMS-QOL mean
score with 95% CI 11.4 (10.5–12.3) 11.1 (10.0–12.1) n/a n/a
Self-efficacy USE-MS mean score
with 95% CI 18.4 (17.0–19.7) 18.2 (16.7–19.6) n/a n/a
3.3. Pet Ownership during the COVID-19 Pandemic
Objective 4. To Explore Effects of the COVID-19 Outbreak on People’s Perceived
Relationships with Their Pets.
No Matched Hypothesis.
In both the control and MS groups, most participants thought that their pet helped
them to cope emotionally and stay fit and active, with positive impacts on their family.
Very few respondents reported pets causing problems in their family or had considered
giving up their pet as a result of the COVID-19 pandemic (see Figures 3 and 4).
Figure 3. Perceptions of pet-owning PwMS during COVID-19.
Figure 4. Perceptions of pet-owning people without MS during COVID-19.
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Pet Ownership-Related Concerns during the COVID-19 Pandemic
In the MS group, 42.7% (n = 47) of participants reported having concerns related to
pet ownership as a result of the COVID-19 pandemic. In total, these 47 PwMS reported
90 individual concerns. In the control group, this value was slightly lower at just 35.2%
(n = 37; OR = 1.37; 95% confidence intervals 0.79–2.60), with a total of 65 individual concerns
reported. An average of 1.9 concerns were reported per PwMS reporting concerns and
1.8 per person in the control group. The most common concern across both the MS and
control groups was access to veterinary care. In the MS group, the next most reported
concern was restrictions on exercise, which was ranked third in the control group, along
with the impacts of returning to work. The second most common concern reported by the
control group was the potential impact of owner illness (see Table 5).




in MS Group Reporting
Concern (n = 110)
% (Number) Respondents
in Control Group Reporting
Concern (n = 105)
Access to veterinary care 28 (31) 18 (19)
Exercise restrictions 14 (15) 8 (8)
Access to food and supplies 11 (12) 6 (6)
Impact of illness 10 (11) 12 (13)
Financial concerns 8 (9) 6 (6)
Return to work 5 (6) 8 (8)
Changes to routine 4 (4) 2 (2)
COVID infection from pets 1 (1) 2 (2)
Other 1 (1) 1 (1)
4. Discussion
This single-center postal questionnaire study investigated attachment to pets and the
associations of pet ownership and attachment on QoL, SPSR, and self-efficacy for people
living with MS for the first time. Having MS was not associated with any differences
in attachment to pets, but attachment was found to be higher in dog owners and lower
in males. Pet ownership and level of attachment were not associated with meaningful
differences in QoL, SPSR, or self-efficacy.
The study also explored the perceived roles of pets during the COVID-19 pandemic
and found that pets were perceived to have positive effects during this time, particularly
as a source of emotional support. However, pet-related concerns were also reported, with
access to veterinary treatment representing the greatest worry for participants in both the
patient and control groups.
4.1. Findings
Objectives and Hypotheses
1. To explore the rates of pet ownership and associations with quality of life, satisfaction
with social roles, and self-efficacy scores in PwMS/pet ownership is associated with
higher rates of quality of life, self-efficacy, and satisfaction with social roles in PwMS
Finding: Although several studies have found pet ownership to improve social par-
ticipation and loneliness, provide emotional support, promote physical exercise, and
in some cases ameliorate chronic pain, a factor known to be associated with a reduced
QoL [11,12,15], the study found no difference in QoL, SPSR, and self-efficacy between pet
owners and non-pet owners living with MS on initial analysis. Introducing a linear model,
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with independent variables of age and sex, MS status, pet ownership, living alone, and
employment status, showed that:
• MS was associated with a reduction in satisfaction with social roles.
• Employment was associated with increased satisfaction with social roles.
• Employment was associated with improved quality of life.
• Employment was associated with increased self-efficacy.
• Pet ownership was associated with a reduction in satisfaction with social roles.
This is in keeping with established findings that doing a job of work (that one enjoys)
is psychosocially beneficial [38,39] and that MS is associated with lower satisfaction with
social roles [22].
No associations were seen between LAPS score and QoL, self-efficacy, and SPSR
in PwMS, which is in keeping with previous work reporting no significant relationship
between attachment to pets, perceived stress, and life satisfaction [40]. Despite this, evi-
dence of an association between attachment and health-related benefits in cat owners, and
attachment and emotional support in dog owners implies that, while attachment may not
be linked to improved overall QoL, self-efficacy, and SPSR, it may be associated with other
important benefits that could vary with pet species [41,42].
2. To compare the levels of attachment to pets in PwMS and people without MS/pet
attachment may be higher in PwMS than in controls.
Finding: Our findings did not support an effect of MS on the level of attachment
to pets. In keeping with previous work, females appeared to experience greater levels
of attachment than males [40,43]. Dog ownership also appeared to be associated with
a greater LAPS score, whilst the effect of cat ownership was unclear. Increased LAPS
scores as a result of dog ownership have been reported previously (although not in recent
COVID-19-related work [29]) and could be attributed to the greater amounts of time spent
with dogs compared to other animals due to an increased requirement for more individual
care including training and exercise [42–44].
3. To compare levels of satisfaction with social roles in pet-owning and non-pet-owning
PwMS and people without MS/satisfaction with social roles may be higher in pet-
owning than non-pet-owning PwMS and controls
Finding: The finding of a reduction in satisfaction with social roles (SPSR) being asso-
ciated with pet ownership was contrary to our hypothesis. It is possible that, particularly
during the time of a pandemic, during a period of heightened stress for many people,
pet ownership added an extra “burden” of work, as the PROMIS Short Form 8a does ask
specifically about being satisfied with one’s “ability to meet the needs of those who depend
on me”, which may be particularly important in view of the high rates of concerns about
pet ownership raised by the respondents to our questionnaires.
4. To explore the effects of the COVID-19 outbreak on people’s perceived relationships
with their pets (how the participants thought their pets helped them emotionally and
physically and whether they had any concerns about being a pet owner during the
COVID-19 pandemic)/no matched hypothesis.
The majority of pet owners in both MS and control groups reported that they felt
that their pets had beneficial effects on their health and wellbeing during the COVID-
19 pandemic. Pets appear to be an important source of emotional support, whilst also
promoting physical exercise, enabling owners to keep fit and active, a benefit that may
be felt particularly amongst dog owners, who have been found previously to participate
in more mild to moderate exercise than other pet owners [29,44,45]. This is important
in the context of the COVID-19 pandemic, which has resulted in poor mental health across
all groups, as well as restrictions on normal activities [25]. However, for PwMS, a group
known to experience high levels of poor mental health, isolation, and reduced exercise,
under normal life conditions, an additional source of emotional support in the form
of a companion may be particularly beneficial [2,46]. The majority (>90%) of respondents
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in both the patient and control groups felt that their pets had been beneficial for the whole
family, during a period that posed a threat to interpersonal relationships due to high levels
of stress and social disruption [47].
The body of literature regarding pet ownership and COVID-19 is growing. There
are generally high levels of agreement that pet ownership can have beneficial effects to
mitigate some of the negative impacts of lockdown, such as low mood, loneliness, and
isolation [29,45,48,49]. People with MS and other disabilities are more likely to experience
these phenomena without being in a pandemic-related lockdown [50–52] and so may be
particularly likely to benefit from pet ownership.
Overall, almost no participants reported that they had considered giving up their
pet due to COVID-19, indicating that concerns around pet ownership were not sufficient
to cause participants to want to give up their animal. However, it has been recognized
that during the pandemic, there have been high rates of adoption or purchasing of pets;
as people return to work, and to the “new normal”, it will be important to see if this
situation changes [53].
Comparisons of the concerns reported by the MS and control group showed similar
rates of concern in both groups but at lower rates than those reported in some previous stud-
ies [29,30]. This could be the result of the relatively small sample size used or differences
in sample populations, for example, due to differing methods of participant recruitment
(online versus postal; open to any respondents versus selected participants). The particular
areas of concern were similar to those shown in previous studies, around access to veteri-
nary treatment [29] and effects on animal exercise, activity and otherwise meeting the needs
of pets [30]. One study has suggested that pet ownership during COVID was associated
with lower life satisfaction, perhaps because of some of these areas of concern [54], but
the responses from our questionnaire were overall more positive than this, with lower
rates of concerns and considerations regarding potentially giving up their pets among our
respondents. Numbers of people with concerns and numbers of concerns per concerned
person were not different between PwMS and controls, suggesting that having MS did not
make people be more likely to have concerns about the effects of COVID-19 on their pet,
or to have a greater number of concerns. However, while access to veterinary treatment
was the most reported concern by both groups, access to food and restrictions on exercise
were ranked higher by the patient group than the control group. These differences could
be contributed to by a greater level of concern about catching COVID-19 and its potential
effects amongst PwMS, especially as the most reported MS subtype was RRMS, the subtype
most associated with use of disease-modifying therapies (DMTs) that can affect the immune
system [28,55,56]. It is also relevant that there was a higher proportion of shielding among
PwMS responding to our questionnaire than in the controls, which may have affected the
ability to access veterinary treatment, shopping, and exercise. Additionally, concerns about
returning to work were ranked higher by the control than the MS group, potentially due to
the lower rates of employment among the patient group compared to the control group.
Concerns related to the impact of owner illness on pet welfare were widely reported
in both groups. It is an important area to address, especially as a study in the US reported
that 10% of pet owners might delay or avoid testing for COVID-19, and over 10% might
delay or avoid treatment, due to concerns about the welfare of their pet, with the lack
of adequate planning for pet care being cited as a key contributing factor by many pet
owners [57]. This could potentially provide a rationale for the promotion of suitable
planning for pets in cases of illness, especially by people with long-term conditions who,
under normal circumstances, may be more likely to experience sudden difficulties with
caring for their pet.
4.2. Limitations
A key limitation of the study was the relatively small sample size and the low response
rate without power calculations, which meant that, although we were able to explore
relationships, we were unable to comment on their significance. Additionally, recruitment
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of the control group was dependent on the patient group, which may have led to a biased
representation as the friends and family of the patient group may be more likely to have
similar opinions or experiences to the patient group.
Our questionnaire was designed to be brief and simple to complete, but this meant
that we did not collect some data that could have been relevant to the study. We only
asked about MS as a diagnosis and no other illnesses, conditions, or disabilities. We only
asked about current pet ownership and did not analyze for factors, such as length of pet
ownership, current health status of pets, or previous pet ownership and subsequent loss.
Furthermore, there are many other variables that could mediate the relationship between
pet ownership and outcome (e.g., number of pets/perceived friendliness of pets/other
sources of social support, etc.), which may have contributed to our findings but which
were not recorded [11,58].
The risk of bias was likely even greater due to the COVID-19 pandemic, which may
have limited the number of people available to ask to complete the survey, leading to family
members, carers, or at least members of the same household being more likely to complete
the questionnaire. If this is indeed the case, then it is possible that the controls’ relationships
with a PwMS could have influenced some of their responses, as a chronic illness, such
as MS, affects all family members, not just the individual patient [59]. The patient and
control group had some important differences, including a higher preponderance of females
in the patient than the control group (which would fit with the female preponderance in this
condition). PwMS were more likely to be medically retired or work from home part-time,
whereas controls were more likely to be working out of the house full time. COVID-19
also impacts on patients and controls differently, with controls being more likely to report
carrying on as normal during the pandemic, and patients more likely to report isolating at
home for longer periods. As a result, in the future, further research should involve more
stringent recruitment of a representative control group to improve the generalizability
of the results. Although we made every effort to include only essential questions, and
instructed respondents to ask for help or to take breaks if required, the questionnaire was
still quite lengthy, at eight pages long, and for people struggling with fatigue, cognitive
impairment, difficulties with reading or writing, or poor concentration for whatever reason,
this may have been overwhelming or simply not possible. There were, perhaps, some steps
that we could have taken to increase the response rate, such as posting out reminders [60],
using an incentive, colored ink, or recorded delivery [61], but finances were limited for this
study. However, these would be important factors to consider for future work.
Answers to the LMS-QoL, USE-MS and PROMIS short form 8a (SPSR) may also
have been influenced by the COVID-19 pandemic, with answers to questions, such as ‘I
have felt lonely’ (LMS-QoL), ‘I find that the things I do in the day make me feel happy
and satisfied’ (USE-MS), and ‘I am satisfied with my ability to work’ (PROMIS SF 8a),
potentially being impacted by the increased isolation and poor mental health associated
with the pandemic [25,27]. Additionally, when analyzing the LAPS results, we only
controlled for a small number of factors known to influence the score. Therefore, future
research should aim to control for a wider range of factors including marital status and
potentially the level of pet caring responsibility [31].
While we chose to use a postal questionnaire to try to ensure accessibility and allow
respondents to take as much time as required to complete it, we recognize that the response
rates were low, and could perhaps have been improved by approaches used in other postal
surveys (e.g., personalization, follow-up contacts, incentives, etc.) [60,61].
The complexity of human–animal interactions and relationships, and their effects
on psychosocial wellbeing arguably may not lend themselves to such quantitative work,
and future work could benefit from including qualitative research, which could better
explore some of these intricacies, including the effects of living with chronic illnesses and
the contribution of pets to the day-to-day management of MS. It will also be important to
embed patient and public involvement in such future work to ensure that any outcomes
studied are relevant to the experience of living with MS.
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5. Conclusions
This study has added to the current body of knowledge on human–animal interactions.
Pet ownership was not found to affect QoL, self-efficacy, or SPSR in PwMS. However, pet
ownership has previously been found to positively affect participation and mental health, as
well as chronic pain, and participants in this study self-reported benefits of pet ownership.
Therefore, further research exploring the impacts of pet ownership as a single facet of life
is required to better understand its contribution to QoL, self-efficacy, and SPSR. The cross-
sectional nature of this work also precluded us from investigating temporal relationships
between the different factors (e.g., whether a PwMS had a lower self-efficacy score before
becoming a pet owner). Relatively few studies have looked at such relationships, although
there is evidence that becoming a dog owner can reduce loneliness levels [62].
Concerns around the impact of owner illness on pet welfare, and evidence from
previous studies that some people would delay or avoid treatment because of this, highlight
the importance of effective pet care plans (i.e., plans for temporary care arrangements
for companion animals if an owner becomes unwell and/or needs hospital admission) as
well as the need for healthcare professionals to consider how pet ownership may affect
treatment-related decisions [57]. This is particularly important for people living with
long-term conditions, such as MS, who may be at an increased risk of sudden illness.
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